为您找到相关结果约500个

你是不是要搜索 期刊CRC患者对抗EGFR治疗的耐药性机制 点击跳转

Liquid biopsy guides anti-EGFR rechallenge in metastatic CRC

Human alpha-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling

Molecular subtype assay to reveal anti-EGFR response sub-clones in colorectal cancer (CRC).

Autophagy (A) inhibition enhances combined immunotherapy (I) and anti EGFR treatment (E) in colorectalcancer (CRC)

Strong Combination of BRAF Inhibitor and anti-EGFR Antibody Targeted treatment of metastatic BRAF(V600E) mutant CRC

Autophagy (A) inhibition to enhance combined immunotherapy (I) and anti-EGFR treatment (E) in colorectalcancer (CRC).

Dysregulation of Epidermal Growth Factor Receptor (EGFR) Signaling Pathway in Mucinous Colorectal Adenocarcinoma(CRC) and CRC with Mucinous Component as Evidenced by High Frequency of KRAS and BRAF Mutations

Metachronous CRC after CRC biopsy: How common is it?

Identification of mechanisms of primary and secondary resistance to anti-egfr and braf inhibition inbrafv600e CRC PDOS and PDX

CRC malignancy continuum

Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Updated resultsfrom the SA metastatic CRC registry.

Bacterial invaders drive CRC progression

Compressive stress strain behavior of crumb rubber concrete (CRC) and application in reinforced CRC slab

Experimental study on crumb rubberised concrete (CRC) and reinforced CRC slabs under static and impact

ARID1A mutations induce an EGFR-like gene expression signature and confer intrinsic and acquired resistanceto cetuximab treatment in first line metastatic CRC

为您找到相关结果约500个

共500条页码: 1/34页15条/页